Integrated BioPharma, Inc. Share Price Other OTC
Equities
INBP
US45811V1052
Pharmaceuticals
Sales 2022 | 56.25M 4.43B | Sales 2023 | 50.67M 3.99B | Capitalization | 9.92M 781M |
---|---|---|---|---|---|
Net income 2022 | 3M 236M | Net income 2023 | - 0 | EV / Sales 2022 | 0.3 x |
Net Debt 2022 | 1.71M 135M | Net Debt 2023 | 1.36M 107M | EV / Sales 2023 | 0.22 x |
P/E ratio 2022 |
4.17
x | P/E ratio 2023 |
-292
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 20.22% |
Managers | Title | Age | Since |
---|---|---|---|
Riva Sheppard
CEO | Chief Executive Officer | 57 | 30/04/91 |
Christina Kay
CEO | Chief Executive Officer | 54 | 30/11/94 |
Dina Masi
DFI | Director of Finance/CFO | 63 | 16/11/05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christina Kay
CEO | Chief Executive Officer | 54 | 30/11/94 |
Damon Desantis
BRD | Director/Board Member | 56 | 19/06/22 |
Eric Friedman
BRD | Director/Board Member | 76 | 03/11/20 |
1st Jan change | Capi. | |
---|---|---|
+38.69% | 723B | |
+34.28% | 595B | |
-4.49% | 369B | |
+20.24% | 332B | |
+2.12% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
-0.35% | 168B |